Effects of ciprofibrate and fenofibrate on liver lipids and lipoprotein synthesis in normo- and hyperlipidemic rats

Atherosclerosis

Volumn 74, Issue 3, 1988, Pages 215-225

  Petit, D ^a   Bonnefis, M T ^a   Rey, C ^a   Infante, R ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

Fibrates; Hyperlipidemic diet; Hypolipidemic drug; Lipoproteins; Liver lipid

Indexed keywords

CIPROFIBRATE; FENOFIBRATE;

HYPERLIPIDEMIA; LIPID BLOOD LEVEL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ANIMAL; APOLIPOPROTEINS; CHOLESTEROL; CLOFIBRATE; CLOFIBRIC ACID; COMPARATIVE STUDY; HYPERLIPIDEMIA; LIPIDS; LIPOPROTEINS; LIVER; MALE; PROCETOFEN; PROPIONATES; RATS; RATS, INBRED STRAINS;

EID: 0024245703     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(88)90240-7     Document Type: Article

References (35)

1. Modification of metabolism and distribution of lipids by ethyl-chlorophenoxy-isobutyrate
2. Metabolic effects of a new hypolipidemic agent, Ciprofibrate
3. The results of animal studies with Ciprofibrate, a new orally effective hypolipidemic drug
4. The use of Ciprofibrate in the treatment of familial hyperlipidaemias
5. Effective therapy in type II hyperlipoproteinemia with a new long acting drug, Ciprofibrate
6. Effect of ciprofibrate treatment on biliary lipids in patients with hyperlipoproteinaemia
7. Hypolipidemic and hypouricemic action of fenofibrate in various types of hyperlipoproteinemia
8. Fenofibrate therapy of hyperlipoproteinemia. A dose-response study and a comparison with clofibrate
9. Blood levels, tissue distribution and the duration of action in rats of ciprofibrate, a new hypolipidemic agent
10. Absorption and disposition of 2-[4-(2,2-dichlorocyclopropyl) phenoxy]-2-methyl propanoic acid, WN 35833, in rats, monkeys and men
11. A relation between non esterified fatty acids in plasma and the metabolism of glucose
12. Amino acid metabolism in hereditary fructosemia
13. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
14. A simple method for the isolation and purification of total lipids from animal tissues
15. Protein measurement with the Folin phenol reagent
16. Measurement of the incorporation of radioactive amino acids into protein by a filter paper disk method
17. Influence of procetofen on lipid metabolism in normocholesteremic rats
18. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study
19. The Tromsø heart study. High density lipoprotein and coronary heart disease: a prospective case-control study
20. Laboratory of 1-methyl-4-piperidyl bis(p-chlorophenoxy) acetate (SaH42-348). A new hypolipidemic agent
21. Dose response study of the effect of ciprofibrate on serum lipoprotein concentrations in hyperlipoproteinaemia
22. Ciprofibrate in the therapy of type II hypercholesterolema. A double-blind trial
23. Drugs affecting the synthesis of glycerides and phospholipids in rat liver: the effects of clofibrate, fenfluramine, amphetamine, cinchocaine, demethylimipramine, imipyramine and some of their derivatives
24. Some aspects of the physiological and pharmacological control of the synthesis of triacylglycerols and phospholipids
25. Increased biosynthesis of CoA in the liver of rats treated with clofibrate
26. Inhibition of monoacylglycerophosphate formation by chlorophenoxyisobutyrate and β-benzalbutyrate
27. The effect of clofibrate on hepatic fatty acid metabolism
28. Hepatic aceto acetyl-CoA deacylase activity in rats fed ethyl chlorophenoxyisobutyrate
29. Influence de produits normolipémiants (clofibrate et procétofène) sur le m'etabolisme des chylomicrons chez le rat
30. Tissue specific induction of peroxisomal fatty acyl-CoA oxidase and peroxisomal bifunctional proteins messenger RNA levels by ciprofibrate
31. Effects of long-term administration of clofibric acid on peroxisomal beta-oxidation, fatty acid binding protein and cytosolic long-chain acyl-CoA hydrolases in rat liver
32. Action of clofibrate and its analogs in rats. Dissociation of hypolipidemic effects and the induction of peroxisomal beta-oxidation
33. Hypolipoproteinaemic effects of ciprofibrate
34. Citrate cleavage enzyme and fatty acid synthesis
35. Clofibrate and nafenopin: effects on plasma clearance and tissue distribution of chylomicron triglyceride in the dog